Impact of gastric neoplasms location on clinical outcome of patients treated by endoscopic submucosal dissection.

BACKGROUND

The location of gastric neoplasms can influence the level of technical difficulty and performance of endoscopic submucosal dissection (ESD). There are few studies that analyze the influence of tumor location in the stomach on ESD outcomes.

AIM

To compare the clinical efficacy and safety of ESD in the proximal distal stomach.

METHODS

A retrospective analysis was conducted on patients admitted in chronological order who received gastric ESD between 2009 and 2024. Patients were stratified into two groups based on tumor location: Group 1 included patients with tumors in the lower third of the stomach, while Group 2 included those with tumors in the middle or upper third. The following parameters were evaluated for each group: procedure duration, curative resection rate, resection rate, complete resection rate, incidence of complications, and depth of neoplastic invasion.

RESULTS

The mean procedure time was 97.07 minutes for lesions located in the distal stomach and 129.08 minutes for those in the proximal stomach ( = 0.0011). resection rates for ESD in the distal and proximal stomach were 97.9% and 85.7%, respectively ( = 0.0016), while complete resection rates were 93.9% and 73.4%, respectively ( = 0.0002). Curative resection was achieved in 90.9% of distal lesions compared to 65.3% of proximal lesions ( = 0.0001). Submucosal invasion was identified in 4.0% of distal lesions and 14.2% of proximal lesions ( = 0.013).

CONCLUSION

ESD performed in the proximal stomach requires a longer procedural time compared to ESD in the distal stomach, independent of lesion size and histopathological characteristics. Additionally, proximal gastric ESD is associated with reduced clinical efficacy and increased incidence of submucosal invasion.